期刊文献+

RNAi沉默RABGEF1基因对人卵巢癌细胞增殖的影响

Effect of silencing RABGEF1 gene by RNAi on cell proliferation of ovarian cancer cell
暂未订购
导出
摘要 目的:探讨沉默RABGEF1基因对人卵巢癌细胞(SK-OV-3细胞)增殖的影响。方法:通过小干扰RNA技术沉默SK-OV-3细胞的RABGEF1基因表达,用实时荧光定量RT-PCR法鉴定细胞内RABGEF1基因的表达水平,培养RABGEF1基因被沉默的SK-OV-3细胞,计数不同时间点的细胞数,分析RABGEF1基因对人卵巢癌细胞增殖的影响。结果:实时荧光定量RT-PCR法检测显示所构建的4个siRNA表达载体对RABGEF1基因表达的沉默率分别为52.5%、58.1%、76.2%和87.7%。将RABGEF1基因表达沉默率为87.7%的SK-OV-3细胞继续培养,计数显示细胞数目较未沉默基因减少(P<0.05)。结论:应用RNAi技术沉默RABGEF1基因可抑制SK-OV-3细胞的增殖,提示RABGEF1基因可能参与卵巢癌的发生发展。 Objective: To explore effect of silencing the RABGEF1 gene expression on cell proliferation of ovarian cancer cell( SK-OV-3). Methods: Expression of RABGEF1 gene was silenced by small interfering RNA in SK-OV-3 cells. Expression level of RABGEF1 gene was determined by real-time quantitative RT-PCR in cultured SK-OV-3 cells. The number of SK-OV-3 cells transfected with the small interfering RNA expression vectors was counted at different times. Effect of the RABGEF1 gene expression on cell proliferation of SK-OV-3 cells was estimated by cellnumber. Results : The silencing rates of the RABGEF1 gene were 52. 5%,58. 1%,76. 2% and87. 7%,respectively,by real-time quantitative RT-PCR for four small interfering RNA expression vectors. The number of SK-OV-3 cells transfected with the small interfering RNA expression vectors with 87. 7% silencing rate reduced( P 0. 05). Conclusion: Silencing the RABGEF1 gene by RNAi can suppress cell proliferation of SK-OV-3 cells,it suggests that RABGEF1 gene may have a role in occurrence and progression of ovarian cancer.
出处 《现代肿瘤医学》 CAS 2014年第12期2809-2811,共3页 Journal of Modern Oncology
基金 深圳市科技计划项目(编号:201202181)
关键词 RABGEF1基因 卵巢癌 增殖 RABGEF1 gene ovarian cancer proliferation
  • 相关文献

参考文献13

  • 1Kalesnikoff J,Rios EJ,Chen CC,et al.Roles of RabGEF1/Rabex-5 domains in regulating Fc epsilon RI surface expression and Fc epsilon RI-dependent responses in mast cells[J].Blood,2007,109(12):5308-5317.
  • 2谢春英,孙顺昌,黄晓东,彭运生.RABGEF1蛋白在卵巢肿瘤中的表达[J].现代检验医学杂志,2013,28(6):39-41. 被引量:1
  • 3孙顺昌,林志坚,陈卫东,贺敬波,彭运生.MSTN基因siRNA表达载体的构建和鉴定[J].医学分子生物学杂志,2009,6(1):13-16. 被引量:4
  • 4孙顺昌,彭运生,贺敬波,林志坚.siRNA阻断鼠成肌细胞myostatin表达对细胞增殖及分化能力的影响[J].基础医学与临床,2011,31(2):187-191. 被引量:7
  • 5Ying B,Campbell RB.Delivery of kinesin spindle protein targeting siRNA in solid lipid nanoparticles to cellular models of tumor vasculature[J].Biochem Biophys Res Commun,2014,446 (2):441-447.
  • 6Sood AK,Coleman RL,Ellis LM.Moving beyond anti-vascular endothelial growth factor therapy in ovarian cancer[J].J Clin Oncol,2012,30(4):345-347.
  • 7Tsai M,Chen CC,Mukai K,et al.Thymic stromal lymphopoietin contributes to myeloid hyperplasia and increased immunoglobulins,but not epidermal hyperplasia,in RabGEF1-deficient mice[J].Am J Pathol,2010,177(5):2411-2420.
  • 8Colicelli J.Signal transduction:RABGEF1 fingers RAS for ubiquitination[J].Curr Biol,2010,20 (15):R630-R632.
  • 9王颖建,厉红元,李焰,闵捷.RABEX-5和RAB5在乳腺癌中的表达及意义[J].四川大学学报(医学版),2011,42(2):185-189. 被引量:4
  • 10Kalesnikoff J,Rios EJ,Chen CC,et al.RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells[J].Proc Nail Acad Sci USA,2006,103(8):2659-2664.

二级参考文献24

  • 1Colussi C, Gaetano C, Capogrossi MC. AAV-dependent targeting of myostatin function: follistatin strikes back at muscular dystrophy[ J ]. Gene Ther, 2008, 15 : 1075 - 1076.
  • 2McNally EM. Powerful genes myostatin regulation of human muscle mass[ J]. N Engl J Med, 2004, 350:2642 - 2644.
  • 3Zhang P, Sridharan D, Lambert MW. Knockdown of mucalpain in Fanconi anemia, FA-A, cells by siRNA restores alphaII spectrin levels and corrects chromosomal instability and defective DNA interstrand cross-link repair [ J ]. Biochemistry, 2010, 49 : 5570 - 558 I.
  • 4Lee YK, Kim KS, Kim JS, et al. Leukemia-specific siRNA delivery by immunonanoplexes consisting of anti-JL1 minibody conjugated to oligo-9 Arg-peptides [ J]. Mol Cells, 2010, 29:457 - 462.
  • 5Schneyer AL, Sidis Y, Gulati A, et al. Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin[J]. Endocrinology, 2008, 149 : 4589 - 4595.
  • 6Anderson SB, Goldberg AL, Whitman M. Identification of a novel pool of extracellular pro-myostatin in skeletal muscle[J]. J Biol Chem, 2008, 283:7027 -7035.
  • 7Nakatani M, Takehara Y, Sugino H, et al. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice[J]. FASEB J, 2008, 22:477 -487.
  • 8Schuelke M, Wagner KR, Stolz LE, et al. Myostatin mutation associated with gross muscle hypertrophy in a child [J]. N Engl J Med, 2004, 350:2682 -2688.
  • 9Yablonka-Reuveni Z. Myostatin blockade: a new way to enhance skeletal muscle repair in old age? [ J ]. Mol Ther, 2007, 15 : 1407 - 1409.
  • 10Cottle DL, McGrath M J, CoMing BS, et al. FHL3 binds MyoD and negatively regulates myotube formation [ J ]. J Cell Sci, 2007, 120:1423-1435.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部